4.6 Review

Hooked on benzodiazepines: GABAA receptor subtypes and addiction

Journal

TRENDS IN NEUROSCIENCES
Volume 34, Issue 4, Pages 188-197

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tins.2011.01.004

Keywords

-

Categories

Funding

  1. National Institute on Drug Abuse (NIDA) [DA019022]
  2. Swiss National Science Foundation
  3. Swiss Initiative in Systems Biology (Neurochoice)

Ask authors/readers for more resources

Benzodiazepines are widely used clinically to treat anxiety and insomnia. They also induce muscle relaxation, control epileptic seizures, and can produce amnesia. Moreover, benzodiazepines are often abused after chronic clinical treatment and also for recreational purposes. Within weeks, tolerance to the pharmacological effects can develop as a sign of dependence. In vulnerable individuals with compulsive drug use, addiction will be diagnosed. Here we review recent observations from animal models regarding the cellular and molecular basis that might underlie the addictive properties of benzodiazepines. These data reveal how benzodiazepines, acting through specific GABA(A) receptor subtypes, activate midbrain dopamine neurons, and how this could hijack the mesolimbic reward system. Such findings have important implications for the future design of benzodiazepines with reduced or even absent addiction liability.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available